System and method for microablation of tissue
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 60/791,194, filed Apr 12, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,078,680 | System and Method for Microablation of Tissue In force · High confidence | Lumenis Be Ltd. | In force | High confidence | ||
| US 10,687,893 | System and Method for Microablation of Tissue In force · High confidence | Lumenis Be Ltd. | In force | High confidence | ||
| US 11,559,354 | System and Method for Microablation of Tissue In force · High confidence | Lumenis Be Ltd. | In force | High confidence | ||
| US 8,496,696 | System and method for microablation of tissue In force · High confidence | Lumenis Be Ltd. | In force | High confidence | ||
| Application 13/314,548 | System and Method for Microablation of Tissue Abandoned Abandoned Oct 25, 2017 | Lumenis Ltd. | Abandoned | Abandoned Oct 25, 2017 | ||
| Application 14/735,172 | System and Method for Microablation of Tissue Abandoned Abandoned Jun 16, 2016 | Lumenis Ltd. | Abandoned | Abandoned Jun 16, 2016 | ||
| Application 14/964,987 | System and Method for Microablation of Tissue Abandoned Abandoned Feb 16, 2021 | Lumenis Ltd. | Abandoned | Abandoned Feb 16, 2021 |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Lumenis Ltd.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.